YOU SEARCHED BY...
SEARCH BY...
Country
- Belgium(1)
- Canada(9)
- China(2)
- France(1)
- Germany(2)
- India(7)
- Israel(1)
- Italia (1)
- Portugal(2)
- Sweden(1)
- Switzerland(4)
- United Kingdom(5)
- United States(110)
Company Spotlight
Quotient Sciences
CMC Pharmaceuticals
Alcami
Contract Service Directory
Curia
Company Headquarters
26 Corporate Circle
Albany, NY 12203
United States
Company Description
Curia, formerly AMRI, is a leading contract research, development and manufacturing organization providing products and services from R&D through commercial manufacturing of large and small molecules to pharmaceutical and biopharmaceutical customers. Curia’s 3,700 employees at 30 locations across the U.S., Europe and Asia help its customers advance from curiosity to cure. Learn more at CuriaGlobal.com.
Contract Service Directory
- Accelerated Stability Studies
- ADMET
- Analytical Laboratory Services
- Analytical Methods Development
- Analytical Validation Studies
- Animal Health
- API Solubilization Technologies
- Aseptic Processing
- Assay Development
- Bioanalytical Analysis LC/MS/MS
- Bioanalytical Services
- Biocatalysis
- Biologics Process Development
- Bioprocess Validation
- Bioprocessing
- Biosimilars
- Cell Line Construction & Development
- cGMP Synthesis
- Chemical Analysis
- Chemistry, Combinatorial
- Chemistry, Medicinal
- Chiral Separations, R&D
- Chromatographic Analysis, LC/GC
- Chromatography
- CMC (Chemistry, Manfacturing & Controls)
- Consulting, Regulatory
- Container Testing
- Contract Development and Manufacturing Organization (CDMO)
- Contract Manufacturing
- Contract Packaging
- Contract Research
- Custom Manufacturing
- Custom Synthesis
- Dosage Form Development
- Downstream Processing
- Drug Delivery Systems
- Drug Design
- Drug Development Services
- Drug Discovery Support Services
- Drug Screening
- Excipients
- Extractables / Leachables Testing
- Fermentation
- Filling, Syringe
- Filling, Vial
- Formulation Development
- Formulation Services
- Fragment-Based Screening
- Granulation
- High Throughput Screening
- HPLC
- In Vitro Testing
- In Vivo Testing
- IND/NDA Submissions
- Informatics
- Lead Optimization
- Library Synthesis
- Lipids/Phospholipids
- Litigation Support & Discovery
- Lyophilization
- Mammalian Cell Culture
- Manufacturing, Antibody-Drug Conjugates
- Manufacturing, API
- Manufacturing, API, High Potency
- Manufacturing, Aseptic Fill/Finish
- Manufacturing, Biologics
- Manufacturing, Clinical Trials Supply
- Manufacturing, Controlled Substances
- Manufacturing, Cytotoxic & High Potency Compounds
- Manufacturing, Dose Form, Non-Sterile
- Manufacturing, Dose Form, Sterile
- Manufacturing, Generics
- Manufacturing, Injectables
- Manufacturing, Liquids
- Manufacturing, Lyophilized Products
- Manufacturing, Ophthalmics
- Manufacturing, OTC
- Manufacturing, Parenterals, Large Volume
- Manufacturing, Parenterals, Small Volume
- Manufacturing, Powders, Non-Sterile
- Manufacturing, Powders, Sterile
- Manufacturing, Solid Dosage
- Manufacturing, Solutions & Suspensions
- Manufacturing, Syringes, Pre-filled
- Manufacturing, Vaccines
- Medicinal Chemistry
- Metabolic Analysis
- Methods Development
- Methods Validation
- Microbial Fermentation
- Micronization
- Microscopic Analysis
- Mixing & Blending
- Packaging, Certification
- Packaging, Closures
- Packaging, Design & Testing
- Packaging, Form/Fill/Seal
- Packaging, Injectables
- Packaging, Parenterals
- Packaging, Services, Other
- Packaging, Unit Dosage
- Parenterals Development
- Parenterals, Syringe Filling
- Parenterals, Vial Filling
- Particle Characterization
- Particle Size Analysis
- Particle Size Classification
- Pharmacology
- Physical Testing
- Pilot-Scale Filling
- Preclinical Testing
- Preclinical Testing Formulations
- Preformulation
- Process Analytical Technology (PAT)
- Process Characterization
- Process Development/Scale-Up Services
- Process R&D
- Process Validation Studies
- Protein Synthesis
- Protein Synthesis, Solid State
- Purification
- Quality Control Testing
- R&D Services
- Raw Materials Analysis
- Regulatory Affairs Consultants
- RNAi Technology
- Scale-Up
- Screening, Classifying
- Spray Drying
- Stability Studies
- Stability, ICH
- Sterile Filling
- Sterility Testing
- Sterilization
- Supplier, Fine Chemicals
- Syringe Filling
- Technology Transfer
- Toxicology Services & Analysis
- Training: cGMP/HPB/FDA Compliance
- Trays, Vial Filling
- Validation, Clinical
- Validation, Equipment Cleaning
- Validation, Filtration
- Validation, Manufacturing
- Validation, Services
- Wet Chemical Analysis
- X-Ray Crystallography
- X-Ray Powder Diffraction
- X-Ray Spectroscopy
Content From Curia
-
The Shift Towards US Pharmaceutical Manufacturing — Considerations in Attaining the Right Global Mix
Effective strategies to secure and de-risk pharmaceutical supply chains and how Curia assures the continual production of urgently needed drugs.White Papers / Tech Papers Released on 06.01.2022
Related Content
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Lonza Further Invests in Drug Product Manufacturing Capabilities
New filling line to process various modalities, including monoclonal antibodies, bioconjugates, viral vectors, and other gene therapy products.09.22.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership
Ink multi-year development and manufacturing agreement for mRNA COVID-19 vaccine candidate, PTX-COVID19-B.09.14.21
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
FUJIFILM Diosynth Biotechnologies, NeuExcell Enter Gene Therapy Mfg. Pact
Aims to rapidly advance NXL-001, a potential neuro-regeneration gene therapy to treat ischemic cortical stroke.09.13.21
-
Drug Development
Partnering with a CDMO for Orphan Drug Development
Challenges and considerations for advancing rare disease drugs to market.Susan Billings, Vice President & Global Head of Business Development, Curia (formerly known as AMRI) 09.09.21
-
APIs | Breaking News | Facilities | Industry News
Curia to Expand U.S. Commercial Manufacturing Capability
Roughly $35 million will be invested to expand manufacturing and product-handling solutions for complex small molecules.08.19.21
-
Breaking News | Facilities | Industry News
WuXi STA Completes Acquisition of BMS Manufacturing Facility
State-of-the-art facility in Couvet, Switzerland enhances WuXi STA's drug product capacity in Europe.08.03.21
-
Breaking News | cGMP Manufacture | Industry News
WuXi Biologics Receives Manufacturing License from German Health Authorities
The inspections comprised areas of cGMP manufacturing required for receiving the permit, as well as commercial production approval.07.26.21
-
Bio News | Breaking News | Industry News | Promotions & Moves
Vibalogics Advances Growth with Leadership Hires
Pharma industry vet Roger Lias joins the CDMO as chief commercial officer.07.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Curia to Acquire US-based LakePharma
Expanding end-to-end R&D capabilities and scale for biologics.07.14.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Fill/Finish | Formulation Development | Industry News | Lyophilization
-
Breaking News | Industry News
AMRI Becomes Curia
New brand reinforces ongoing expansion of expertise, capabilities and contributions to health care.07.12.21
-
Formulation Development
Tryp Therapeutics Partners with Alcami for Proprietary Formulations
The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp’s PFNTM program.
-
Lonza and ValenzaBio Enter Clinical Manufacturing Agreement
Lonza will provide drug substance and drug product manufacturing under accelerated timelines for monoclonal antibody treatment at Guangzhou facility.06.21.21
-
Breaking News | Facilities | Industry News | Lyophilization
Horizon Therapeutics Buys EirGen Manufacturing Facility
The 44,000 square foot facility in Ireland includes fill-finish and analytical laboratory capabilities with potential for site expansion.06.17.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Samsung Biologics Signs Agreement with Kahr Medical
Will support Kahr’s drug candidate DSP502, a TIGITxPD1 fusion protein.Charles Sternberg, Assistant Editor 06.03.21
-
Analytical Services | Bioanalytical Services | Breaking News | cGMP Manufacture | Drug Development | Industry News | R&D
AMRI Adds R&D and Mfg. Solutions for Orphan Products
Targeted investments globally expand scale and compound handling capabilities at facilities in Albany, Grafton, and Glasgow.Kristin Brooks 04.30.21
-
AJILITY: Intelligent Drug Product Manufacturing
The AJILITY platform streamlines your drug product manufacturing program, helping you get lifesaving therapeutics to patients in less time with less complexity.
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement
Expands scope of Aji Bio-Pharma's service offerings to include aseptic fill finish services at its San Diego, CA facility.Kristin Brooks 03.30.21
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News
Piramal Pharma Solutions, Plus Therapeutics Ink MSA
Piramal to perform services related to the development, manufacture, and supply of Plus Therapeutics’ RNL-Liposome Intermediate Drug Product.Kristin Brooks 03.24.21
-
Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Plus Therapeutics, Piramal Ink Master Services Agreement
Development, manufacturing and supply deal is for Plus’ Rhenium NanoLiposome intermediate drug product.Tim Wright, Editor, Contract Pharma 03.23.21
-
Bio News | Biologics, Proteins, Vaccines | Facilities | Industry News
Arranta Bio Invests in New Manufacturing Facility
Addition of 130,000 sq. ft. Boxborough, MA, manufacturing facility to supply clinical and commercial microbiome products.Tim Wright, Editor, Contract Pharma 03.09.21
-
Drug Delivery | Parenterals
Injectable Drug Delivery Trends
How medication trends are driving the shift to patient-friendly drug delivery systems.Peter Soelkner, Managing Director, Vetter 03.01.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
AMRI Contributes to Efforts to Increase COVID-19 Vax Supply
Joins network of approved manufacturers of lipid excipients for Pfizer-BioNTech COVID-19 vaccine.Tim Wright, Editor, Contract Pharma 02.25.21
-
Breaking News | Industry News | Promotions & Moves
AMRI Makes Executive Move
Appoints Scott Waldman to lead corporate development.Tim Wright, Editor, Contract Pharma 02.08.21
-
Parenterals
Parenteral Drug Delivery Trends
A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.Kristin Brooks, Managing Editor, Contract Pharma 01.27.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Humanigen, Emergent Enter Covid-19 Partnership
Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.Tim Wright, Editor, Contract Pharma 01.25.21
-
APIs | Breaking News | cGMP Manufacture | Fill/Finish | Industry News
LSNE Expands Fill Finish and Lyophilization Ops
New automated fill line at Bedford Campus adds ready-to-use aseptic filling and freeze-dryer capacity.Contract Pharma Staff 01.14.21
-
Breaking News | cGMP Manufacture
Ajinomoto Bio-Pharma and Revance Therapeutics Partner
Sign manufacturing agreement for supply of DaxibotulinumtoxinA for injection.Contract Pharma Staff 12.22.20
-
Aseptic Processing | Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News | Scale-up/Technology Transfer
Recipharm Inks Covid-19 Vax Pact with Moderna
Signs of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273).Contract Pharma Staff 12.01.20
-
APIs | Breaking News | Facilities | Industry News
CordenPharma Colorado Increases US Peptide Manufacturing Capacity
Long-term expansion initiative approved to further increase flexibility, efficiency and ultimately, cost-effective production.Contract Pharma Staff 11.25.20
-
Pre-filled Syringes & Injectable Drug Trends
Pre-filled syringes have become a preferred format, as they make it easier to handle drugs and increase dos- ing accuracy.11.23.20
-
Breaking News | Collaborations & Alliances | Industry News
AMRI Named Exclusive API Supplier for Recently Approved Acne Treatment
FDA approved Cassiopea’ Winlevi cream 1% in August 2020.Contract Pharma Staff 11.06.20
-
Aseptic Processing | Breaking News | Facilities | Fill/Finish | Industry News | Parenterals
Argonaut Manufacturing Services Completes First cGMP Run
New automated aseptic fill/finish line for clinical and commercial use was recently approved by regulators.Contract Pharma Staff 11.06.20
-
Breaking News | Clinical Trials
CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin
Phase 2 trial will commence during the first quarter of 2021.Contract Pharma Staff 10.20.20
-
Breaking News | Collaborations & Alliances | Industry News
BryoLogyx Completes World’s First GMP Synthesis of Bryostatin-1
Partnered with CDMO AMRI for GMP synthesis.Contract Pharma Staff 10.13.20
-
APIs | Breaking News | Facilities | Industry News
Sterling Pharma Solutions Expands US Operations
Acquires Alcami’s Germantown, WI API facility.Contract Pharma Staff 10.02.20
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
AMRI to Provide Sterile Fill/Finish Mfg. for AstraZeneca’s COVID-19 Vax
To supply the vaccine candidate AZD1222 from AMRI’s drug product manufacturing facility in Albuquerque, NM.Contract Pharma Staff 09.08.20
-
A Guide to Vaccine Development from Lubrizol Life Science
The current COVID-19 pandemic emphasizes the need for safe and effective vaccines against new pathogens.
-
Breaking News | Industry News
AMRI Increases HCQ Production in U.S.
Ready to meet potential COVID-19 demandContract Pharma Staff 05.04.20
-
Breaking News | Formulation Development | Industry News
Catalent, Bridge Therapeutics Execute Exclusive License Agreement
To utilize Catalent’s Zydis orally disintegrating tablet (ODT) technology for opioid addiction therapeutic product12.10.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
WuXi Biologics Makes Second Major Investment in Ireland
To build a $240 million vaccine manufacturing facility on its Dundalk site.12.09.19
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
WuXi Vaccines to Build a New Vaccine Mfg. Facility in Ireland
Dedicated facility will supply a vaccine product of a large global pharma for the global market11.25.19
-
Aseptic Processing | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Fill/Finish | Parenterals
Contract Pharma’s 20th Anniversary Series: Vetter
Oskar Gold of Vetter discusses vital changes in the industry and the science and technology needed to support advanced therapeuticsKristin Brooks, Contract Pharma 11.13.19
-
German Pharma Benefiting From a Brexit Boost?
Germany consolidates itself as world leader in pharma according to the CPhI Pharma Index.10.29.19
-
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Translate Bio, AMRI Enter Manufacturing Agreement
Agreement provides Translate Bio with customized and dedicated manufacturing space for cGMP mRNA production for current and future programs09.30.19
-
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Lonza, Citryll Enter Manufacturing Partnership
Lonza to supply final drug product in finished format for Citryll’s clinical studies09.10.19
-
Clinical Trials | CRO News | Drug Development
AES Acquires Bioclinica's Clinical Research Site Biz
Expands global footprint and position in patient access and site conduct09.06.19
-
Analytical Services | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News
Permira Funds to Acquire Cambrex in $2.4B Transaction
To back Cambrex in its next phase of growth08.07.19
-
Bio News | Breaking News | Collaborations & Alliances | Industry News | Injectables | R&D
-
Breaking News | Industry News
Eurofins Amatsigroup Rebrands to Eurofins CDMO
Provides integrated, end-to-end solutions for pre-clinical and clinical outsourcing services07.31.19
-
Promotions & Moves
MHI Appoints National Accounts Manager
McCracken to help lead sales for emerging player in North American blister machinery market07.18.19
-
Ergomed Proposes Appointment of Former Chiltern CEO
Dr. Jim Esinhart to be appointed as a Non-Executive Director of the Company07.10.19
-
Lyophilization
-
Breaking News | CRO News | Industry News | R&D
-
Breaking News | Industry News
Whitehouse Labs Bolsters Impurity Testing Capacity
Adds new mass spectrometer to detect contaminating trace metals at levels as low as parts per trillion10.08.18
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
AMRI, Metrion Enter Drug Discovery Collaboration
Agreement enables customers to access a broader range of drug discovery expertise09.05.18
-
APIs | Breaking News | Industry News
-
Industry News | Promotions & Moves
AMRI Appoints CIO
Prakash Pandian joins AMRI from Biogen Corp., where he served as the functional CIO and head of Corporate Systems IT06.12.18
-
APIs | cGMP Manufacture | Industry News
AMRI Launches Aseptic API Line
Investment provides additional capacity, technology and capabilities for increasing demand for sterile API05.09.18
-
APIs | Bio News | Industry News | Promotions & Moves
AMRI Appoints New VP
Steven J. Lichter brings over three decades of experience to the role of senior vice president and general manager, API05.08.18
-
Industry News | Promotions & Moves
AMRI Appoints SVP of Quality
Most recently a vice president at Abbott, Diane M. Beno has over three decades of industry experience04.30.18
-
Analytical Services | Industry News
AMRI Expands NMR Spec Capabilities in Europe
Adds Bruker AVANCE NEO 600 MHz NMR Spectrometer04.23.18
-
Breaking News | Industry News | Promotions & Moves
Heritage Pharma Makes Leadership Changes
William Marth named president and CEO, North America and Europe; John Denman now president of Heritage Pharmaceuticals Inc.04.20.18
-
Breaking News | Drug Discovery | Industry News
AMRI Renews NIH Contract
Re-ups 10-year NIH contract to support the Blueprint Neurotherapeutics Network04.20.18
-
Analytical Services | Breaking News | Industry News | Parenterals
AMRI Highlights Suite of Contract Services
Visit Booth 1129 at Interphex 2018 to learn more about the complete suite of drug development and manufacturing solutions04.17.18
-
Analytical Services | Bioanalytical Services | Biologics, Proteins, Vaccines | Industry News | Reader Showcase
SSCI Implements New Instruments
Mettler Toledo’s thermal analysis instruments meet the updated regulatory data integrity standards03.29.18
-
Bio News | Drug Development | Facilities | Industry News | Laboratory Testing
AMRI Expands CCIT Services
Their container closure integrity testing is specifically expanding into the European Union02.22.18
-
Industry News | Promotions & Moves
AMRI Appoints CFO
Anthony Mattacchione was also appointed senior vice president, and comes with several decades of experience02.21.18
-
Promotions & Moves
-
Analytical Services | Industry News
AMRI Offers Stand-Alone Impurity Services
New regulatory requirements drive increase in analytical testing services10.13.17
-
cGMP Manufacture | Drug Development | Regulatory Affairs
Contracting & Outsourcing Session Highlights and Key Takeaways
Insight into CMO Trends, Biotrends, Manufacturing Compliance, FDA Quality Agreements, and CMO OversightKristin Brooks, Contract Pharma 10.09.17
-
Laboratory Testing | Packaging & Tracking
Whitehouse Labs Increases Testing Resources
Adds USP 661.1 and 661.2 Packaging Qualification10.05.17
-
Analytical Services | Breaking News | Industry News
AMRI Introduces Forced Degradation Services
Supporting the development and commercialization of all facets of drug substance, product09.05.17
-
-
Breaking News | cGMP Manufacture | CRO News | Drug Development | Drug Discovery | Industry News
-
Analytical Services | APIs | cGMP Manufacture | Clinical Trial Materials | Drug Development | Drug Discovery | Financial Reports
-
Analytical Services | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News | Process Development
AMRI Wins Five-Year NIH Contract
To provide drug substance development and manufacturing services05.02.17
-
Financial Reports
-
Breaking News | Collaborations & Alliances | Industry News
AMRI Forms Agreement with Accord Healthcare
Will jointly develop, manufacture and commercialize parenteral drug products02.21.17
-
Analytical Services | Breaking News | Collaborations & Alliances | CRO News | Drug Discovery | Industry News
-
Analytical Services | Chemistry | Fill/Finish | Industry News
Whitehouse Labs, AMRI Increase E&L Expertise
Adds staff and critical instrumentation to the E&L group01.18.17
-
APIs | Breaking News | Collaborations & Alliances | Industry News
AMRI Forms API Supply Agreement with Shire
Marks the second such agreement between the two drug firms12.01.16
-
Financial Reports
-
Promotions & Moves
-
Drug Development | Promotions & Moves | R&D
Valeant Appoints Chief Quality Officer
Yu brings more than 30 years of leadership experience in Quality and R&D functions10.07.16
-
Breaking News | Industry News
-
Breaking News | Drug Discovery | Industry News
AMRI Licenses CRISPR-Cas9 Gene Editing Technology
Will continue to use the technology to enhance its drug discovery service offerings08.30.16
-
Analytical Services | Drug Discovery | Industry News
AMRI, UAlbany in RNA Therapeutics Alliance
Aims to advance development of RNA-based therapeutics and research tools08.16.16
-
Financial Reports
Financial Report: AMRI
Contract revenue up 37%, driven largely by addition of Gadea Pharmaceuticals08.04.16
-
Chemistry | Drug Development | Drug Discovery | Industry News
-
Drug Discovery | Promotions & Moves
AMRI Adds Quality and Compliance Role
Yu to oversee quality and cGMP compliance in all divisions05.10.16
-
APIs | Breaking News | cGMP Manufacture | Facilities | Industry News
-
Breaking News | Chemistry | Drug Discovery | Industry News
SSCI Adds ROD SuperNova Diffraction System
Enhances early development support for targeting a crystalline form04.05.16
-
Financial Reports
-
APIs | Inspections
The Western API Industry
Temporary reprieve or lasting recovery?Dr. Enrico T. Polastro, Arthur D. Little 01.28.16
-
Chemistry | Collaborations & Alliances | Drug Discovery
AMRI, NYCNMR in Nanotech Services Alliance
Will co-market nanoscale, formulation and discovery services01.14.16
-
Analytical Services | Chemistry | Drug Discovery | Industry News | Laboratory Testing
-
Analytical Services | APIs | cGMP Manufacture | Clinical Trials | Collaborations & Alliances | Drug Development | Formulation Development | Parenterals | Preclinical Outsourcing
Eagle Pharma and AMRI Team Up
Together will develop, manufacture and commercialize parenteral drug products01.11.16
-
Analytical Services | Industry News | Laboratory Testing | Methods Development | Process Validation | Validation
-
Analytical Services | Chemistry | Collaborations & Alliances | Drug Discovery | Preclinical Outsourcing
AMRI, Multispan in Drug Discovery Services Pact
Alliance aims to increase success in GPCR drug discovery12.14.15
-
Analytical Services | Chemistry | Drug Development | Drug Discovery | Industry News | Laboratory Testing
AMRI Launches Integrated Drug Discovery Center
Aims to increase translation to the clinic leveraging biology, HTS, medicinal chemistry and pharmacology within a single site12.07.15
-
Clinical Trial Materials | Clinical Trials | Cold Chain Management | Drug Discovery | Information Technology | Logistics | Validation
Cryogenic Cold Chain Risk Mitigation
Mark Sawicki of Cryoport explains the requirements, challenges, and regulatory aspects around cryogenic logisticsKristin Brooks, Contract Pharma 11.13.15
-
APIs | Drug Development
-
Breaking News | Drug Discovery | Promotions & Moves
AMRI Appoints Discovery and Development SVP
Conway to head up the global Discovery and Development Services09.03.15
-
APIs | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Scale-up/Technology Transfer
AMRI Forms Agreement with Saneca Pharmaceuticals
Significantly expands AMRI’s portfolio of controlled substances09.02.15
-
APIs | Breaking News | Drug Development | Industry News | Lyophilization
AMRI Acquires Gadea Pharmaceutical
Expands API portfolio with specialty and generic APIs and establishes strong European ops07.16.15
-
APIs | Facilities | Scale-up/Technology Transfer
APIs: Looking For An Indian Angle
Generic majors zoom in as CMOs boost capacitiesS. Harachand, Contributing Editor 07.14.15
-
APIs | Bioassay Development | Breaking News | Drug Development | Financial Reports | Methods Development | Process Development | Toxicology
-
APIs | Breaking News | Industry News
AMRI to Close Holywell Site
Activities will be transitioned to other facilities, affecting approx. 62 positions04.06.15
-
APIs | Clinical Trials | Drug Discovery | Industry News
Consolidation in Outsourcing
Reviewing 2014’s M&A activityMichael A. Martorelli , Director, Fairmount Partners 03.06.15
-
Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | Financial Reports | GMPs/GCPs | Lyophilization | Process Development
-
Breaking News | Information Technology | Promotions & Moves
-
APIs | Bioassay Development | Breaking News | Capsules | Chemistry | Clinical Trial Materials | Clinical Trials | Drug Development | Drug Discovery | Extractables and Leachables | Facilities | Fill/Finish | Formulation Development | GMPs/GCPs | Industry News | Lyophilization | Methods Development | Process Development | Solid Dosage/Semi-solids | Supply Chain | Toxicology
AMRI Wins 10-Year NIH Contract
Will support development and manufacture of drug candidates for neurological disorders01.19.15
-
Analytical Services | Breaking News | Capsules | cGMP Manufacture | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Parenterals | Process Development
AMRI, Genovi Enter Parenteral Supply Pact
AMRI to provide cGMP manufacture and analytical support for five candidates01.12.15
-
Breaking News | Promotions & Moves
-
Analytical Services | Bioassay Development | Breaking News | Capsules | Chemistry | Clinical Trial Materials | Drug Development | Drug Discovery | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Methods Development | Process Development | Toxicology
Aptuit Divests Two Sites to AMRI
Expands AMRI's drug product development and aseptic clinical manufacturing capabilities01.09.15
-
Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Parenterals | Process Development
-
Breaking News | Financial Reports
-
Breaking News | Financial Reports
-
Breaking News | Cytotoxics and High Potency Manufacturing | Drug Development | Fill/Finish | Industry News | Injectables | Parenterals
AMRI to Acquire Oso Bio Manufacturing
Expands commercial manufacturing capabilities for specialty injectables06.02.14
-
Breaking News | Financial Reports
-
Bioassay Development | Breaking News | Drug Development | Drug Discovery | Industry News | Methods Development | Process Development | Toxicology
-
Breaking News | Drug Development | Industry News
AMRI Completes Cedarburg Acquisition
Expands resources for complex drug development services and products04.07.14
-
APIs | Breaking News
-
APIs | Breaking News | Chemistry | Drug Development
-
APIs | Breaking News | Chemistry | Drug Development | Industry News
-
Breaking News | Financial Reports
-
APIs | Breaking News | Promotions & Moves
AMRI Appoints API GM, India Director
Svokos, Batra bring experience from TevaKristin Brooks 01.10.14
-
Breaking News | Financial Reports
-
Breaking News | Cytotoxics and High Potency Manufacturing | Industry News | Inspections | Lyophilization | Parenterals
-
Breaking News | Chemistry | Promotions & Moves
-
Breaking News | Capsules | Clinical Trial Materials | Clinical Trials | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development
-
Breaking News | Drug Development | Promotions & Moves | Supply Chain
-
Breaking News | Financial Reports
-
Breaking News | Industry News | Inspections
FDA Completes Re-inspection of AMRI Facility
Issues Form 483 for three inspectional observations07.23.13
-
Breaking News | GMPs/GCPs | Industry News | Inspections | Parenterals | Regulatory Affairs
AMRI Burlington Site Gains DEA Approval
Registered to handle Schedule 2 and 2N controlled substances06.18.13
-
Breaking News | Promotions & Moves
AMRI Names BD Director
Collins to lead North American discovery business development activities06.17.13
-
Breaking News | Drug Discovery | Promotions & Moves | Supply Chain
-
Breaking News | Financial Reports
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Development | Drug Discovery
-
APIs | Inspections | Logistics | Supply Chain
Generic Manufacturing: GDUFA & CMOs
Generic facility fees cause sticker shockGil Y. Roth, Contract Pharma 03.06.13
-
Breaking News | Chemistry | Drug Discovery | Promotions & Moves
-
APIs | Breaking News | Chemistry | Collaborations & Alliances | Process Development
-
Breaking News | Financial Reports
-
Bioassay Development | Breaking News | Collaborations & Alliances | Drug Development | Methods Development | Process Development | R&D | Toxicology
-
APIs | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Inspections | Lyophilization | Process Development
-
APIs | Breaking News | Promotions & Moves
-
Breaking News | Capsules | Collaborations & Alliances | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development
-
Breaking News | Drug Discovery | Industry News | Methods Development
-
Analytical Services | APIs | Breaking News | Chemistry | Drug Development | Formulation Development | Promotions & Moves
Cambridge Major Appoints SciTech VP
Raje to provide strategic leadership for API organization11.27.12
-
Breaking News | Financial Reports
-
Breaking News | cGMP Manufacture | Promotions & Moves
-
Analytical Services | APIs | Bioanalytical Services | Bioassay Development | Breaking News | Capsules | Chemistry | Extractables and Leachables | Facilities | Fill/Finish | Formulation Development | GMPs/GCPs | Lyophilization | Methods Development | Process Development | Promotions & Moves | QA/QC | Regulatory Affairs | Solid Dosage/Semi-solids | Toxicology | Validation
-
Breaking News | Industry News
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Discovery | Methods Development
AMRI, Knopp Biosciences In CNS Discovery Pact
Combines drug discovery capabilities with CNS experience09.17.12
-
Breaking News | Promotions & Moves
-
Breaking News | Promotions & Moves
-
APIs | Breaking News | Process Development | Promotions & Moves
-
Breaking News
-
Chemistry | Drug Discovery
-
Breaking News | Chemistry | Drug Discovery | Methods Development | Promotions & Moves | Toxicology
AMRI Expands Discovery Capabilities in India
Hires two, relocates custom library synthesis resourcesGil Roth 06.20.12
-
Aseptic Processing | Breaking News | Capsules | Collaborations & Alliances | Drug Delivery | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development | Scale-up/Technology Transfer | Solid Dosage/Semi-solids | Validation | Vials
AMRI To Fill Excellagen for Cardium
Burlington site to handle sterile pre-filled syringesGil Roth 06.05.12
-
Breaking News | Promotions & Moves
-
Breaking News | Financial Reports
-
Breaking News | Drug Discovery | Promotions & Moves
-
Breaking News | Clinical Trials | Collaborations & Alliances | Drug Discovery
AMRI, Biota in Development Deal
Could lead to commercial manufacturing of neuraminidase inhibitor04.17.12
-
Bioassay Development | Breaking News | Drug Development | Industry News | Methods Development | Process Development | R&D | Toxicology
-
Breaking News | Parenterals | Promotions & Moves | Vials
-
Breaking News | Parenterals | Promotions & Moves | Vials
-
APIs | Breaking News | Industry News | Inspections
-
Breaking News
-
Bioassay Development | Breaking News | Capsules | Collaborations & Alliances | Drug Development | Drug Discovery | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Methods Development | Process Development | Toxicology
AMRI in Preferred Provider Pact with BioPontis
AMRI will anchor small molecule discovery, CMC services01.05.12
-
Breaking News | Chemistry | Industry News | Toxicology
AMRI Accelerates Restructuring
New initiative expected to bring annual savings to $10 millionGil Roth 12.22.11
-
Analytical Services | APIs | Bioanalytical Services | Bioassay Development | Chemistry | Drug Development | Excipients | Methods Development | Process Development | Toxicology
Trace Impurity Identification
A combination of spectrometric and spectroscopic techniquesDennis J. Milanowski and Ulla Mocek 11.14.11
-
Breaking News | Chemistry | Drug Discovery
-
Breaking News | R&D
Financial Report: AMRI 3Q11
Achieves 17% growth in large-scale manufacturing, exits internal pharma R&D11.08.11
-
APIs | Breaking News
-
Breaking News | Chemistry | Drug Development | Drug Discovery | Toxicology
AMRI Names DMPK Director
Jensen will work to enhance discovery biology and chemistry platform09.12.11
-
Biologics, Proteins, Vaccines | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Process Development | Scale-up/Technology Transfer | Validation
-
Bioassay Development | Breaking News | Chemistry | Clinical Trials | Drug Development | Drug Discovery | Methods Development | Process Development | Toxicology
-
APIs | Breaking News | Capsules | Drug Discovery | Extractables and Leachables | Facilities | Fill/Finish | Financial Reports | GMPs/GCPs | Lyophilization | Methods Development | Process Development
Financial Reports: AMRI 2Q11
Discovery services down, but other businesses on the rise.Gil Roth 08.08.11
-
Breaking News | Chemistry | Drug Discovery | Methods Development | Promotions & Moves
-
APIs | Breaking News | Capsules | Drug Discovery | Formulation Development | Promotions & Moves | Solid Dosage/Semi-solids
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Discovery | Methods Development
AMRI, Proteros Crystallize Pact
Proteros to add protein crystallization, X-ray structural analysis to AMRI discovery offeringsGil Roth 06.29.11
-
Breaking News | Collaborations & Alliances
-
Breaking News | Financial Reports
-
APIs | Breaking News | Industry News | Process Development
AMRI, Parnell in Development and Supply Pact
AMRI and Parnell Manufacturing Pty Ltd. have entered into a development and commercial supply agreement, under which AMRI will provide process development, manufacturing and supply of APIs to support Parnell’s New Animal Drug Application (NADA) with04.07.11
-
Breaking News | Promotions & Moves
-
Breaking News | Financial Reports
-
Breaking News | Fill/Finish | Industry News | Vials
AMRI Receives AIFA Certification
AMRI has received approval from the Italian Medicines Agency (AIFA) for its Burlington, MA facility to manufacture the commercial drug product octreotide for a customer in the EU.02.04.11
-
Breaking News | Promotions & Moves
-
Breaking News | Chemistry | Drug Discovery | Promotions & Moves
AMRI
Takeshi Yura, Ph.D. has been appointed assistant director, medicinal chemistry at AMRI.01.28.11
-
Breaking News | Chemistry | Drug Discovery | Industry News | R&D
AMRI Consolidates Drug Discovery Platform
AMRI has merged its Discovery R&D and Discovery Chemistry departments to form a Global Drug Discovery organization.01.06.11
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Discovery
AMRI, Genentech Enter Research Pact
AMRI has entered a research and licensing agreement with Roche subsidiary Genentech to develop antibacterial compounds from AMRI’s natural products sample collection.01.04.11
-
Breaking News | Financial Reports
-
Breaking News | Chemistry | Process Development | Promotions & Moves
AMRI
David C. Lathbury, Ph.D. has been appointed vice president of chemical development at AMRI.10.12.10
-
Breaking News | Trials & Filings
AMRI Advances IBS Drug
AMRI has selected a compound from its research program for the treatment of irritable bowel syndrome (IBS) to advance to preclinical testing.09.14.10
-
AMRI Advances IBS Drug
AMRI has selected a compound from its research program for the treatment of irritable bowel syndrome (IBS) to advance to preclinical testing.09.14.10
-
Breaking News | Drug Discovery | Promotions & Moves
-
APIs | Breaking News | Chemistry | Drug Discovery | Industry News
AMRI Receives Pfizer Innovation Award
AMRI has been selected for Pfizer’s Route Design Innovation Award, for sharing innovative ideas for process chemistry and large scale Active Pharmaceutical Ingredient (API) production.08.16.10
-
Breaking News | Chemistry | Collaborations & Alliances
Aquapharm, AMRI Enter Chemistry Collaboration
Aquapharm Biodiscovery, a marine biotechnology company, has signed a research agreement with Albany Molecular Research (AMRI) to identify novel drug-like compounds and scaffolds with anti-microbial and anti-inflammatory activity from Aquapharm’s col07.07.10
-
APIs | Parenterals
-
APIs | Breaking News | Industry News | Parenterals
-
Breaking News | Industry News | Injectables
-
Breaking News | Promotions & Moves | Regulatory Affairs
Harlan Laboratories, Inc.
Dr. Hilton Klein has been named global vice president, science and new product introduction for the research models and services operating group at Harlan Laboratories.06.03.10
-
Breaking News | Industry News
AMRI Restructures U.S. Ops, Expands in Asia, Europe
AMRI has plans to restructure its U.S. operations and to expand its services in Asia and Europe.05.26.10
-
Breaking News | Financial Reports
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Discovery
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Discovery
AMRI, Navigen Enter Research Pact
AMRI has entered a multi-year research collaboration with Navigen Pharmaceuticals focused on the development of new drug therapies.04.13.10
-
Breaking News | Industry News
AMRI Acquires UK-based Excelsyn
AMRI has acquired Excelsyn Ltd., a provider of chemical development and manufacturing services, located in North Wales, UK, for $19 million in cash.02.18.10
-
APIs | Breaking News | Industry News
AMRI Gains Potent API Safety Certification
AMRI has received certification of its high potency research labs and GMP-manufacturing facilities in Rensselaer, NY for the safe handling of potent APIs by SafeBridge Consultants, Inc.01.19.10
-
Breaking News | Financial Reports
-
APIs | Clinical Trials | Drug Development | Injectables
-
Breaking News | Financial Reports
-
Breaking News | Chemistry | Industry News | R&D
AMRI Completes Budapest R&D Site
AMRI has finished the construction of a new state-of-the-art chemistry R&D facility in Budapest, Hungary.06.22.09
-
Analytical Services | Breaking News | Promotions & Moves
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Discovery
AMRI, CHDI Enter Huntington’s Pact
AMRI and CHDI Foundation entered a collaboration agreement focused on the discovery of new therapies for the treatment of Huntington’s disease (HD).04.29.09
-
Breaking News | Drug Discovery | Industry News | R&D
AMRI Relocates Bothell R&D Facility
AMRI has completed the relocation of its Bothell, WA research unit into approximately 44,000 sq.-ft. of nearby newly refurbished lab and office space.04.20.09
-
Breaking News | Information Technology | Logistics | Promotions & Moves
AMRI
Chief financial officer Mark T. Frost has been promoted to senior vice president, administration and chief financial officer, AMRI.03.04.09
-
Breaking News | Financial Reports
Financial Report: AMRI 4Q
Contract revenue for the quarter, which includes Discovery Services, Development and Small Scale Manufacturing, and Large Scale Manufacturing, was $49.6 million (+22%) and $195.5 million for the year (+20%).02.09.09
-
Breaking News | Promotions & Moves
AMRI
Richard A. Saffee has been named general manager of large scale manufacturing at AMRI.02.05.09
-
Breaking News | Promotions & Moves
-
APIs | Breaking News | Chemistry | Clinical Trial Materials | Promotions & Moves | Regulatory Affairs
-
Breaking News | Financial Reports
-
Breaking News | Drug Discovery | Industry News
-
Breaking News | Clinical Trials | Drug Development | Promotions & Moves
-
Analytical Services | Breaking News | Chemistry | Drug Discovery | Promotions & Moves | Validation
-
Breaking News | Chemistry | Promotions & Moves | Regulatory Affairs
-
Breaking News | Clinical Trials | Trials & Filings
-
Clinical Trials
-
Breaking News | Chemistry | Drug Discovery | Industry News
-
Breaking News | Collaborations & Alliances
-
Breaking News | Chemistry | Drug Discovery | Promotions & Moves
-
Breaking News | Financial Reports
-
Breaking News | Financial Reports
-
Breaking News | Clinical Trial Materials | Custom Sourcing News
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Discovery
-
Breaking News | Promotions & Moves
-
APIs | Breaking News | Chemistry | Custom Sourcing News | Drug Discovery
-
Breaking News | Financial Reports
-
Breaking News | Collaborations & Alliances
-
Breaking News | Clinical Trial Materials | Industry News | Supply Chain
-
Breaking News | Financial Reports
-
Breaking News | Industry News
-
Breaking News | Promotions & Moves | Supply Chain
-
Breaking News | Financial Reports
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Discovery
-
Breaking News | Chemistry | Clinical Trials | Drug Development | Promotions & Moves
-
Breaking News | Chemistry | Custom Sourcing News
-
Breaking News | Financial Reports
-
Breaking News | Chemistry | Clinical Trials | Trials & Filings
-
Chemistry | Clinical Trials
-
Breaking News | Financial Reports
-
Breaking News | Custom Sourcing News
-
APIs | Breaking News | Chemistry | Drug Discovery | Industry News
-
Breaking News | Financial Reports
-
Breaking News | Chemistry | Drug Discovery | Industry News
-
Chemistry | Clinical Trials | Drug Development | Drug Discovery
Drug Discovery: Outsourcing Chemistry
How has genomics and proteomics altered the chemistry outsourcing arena?Gil Y. Roth 08.22.05
-
Analytical Services | APIs | Bioanalytical Services | Bioassay Development | Capsules | Chemistry | Drug Development | Drug Discovery | Extractables and Leachables | Facilities | Fill/Finish | Formulation Development | GMPs/GCPs | Lyophilization | Methods Development | Preclinical Outsourcing | Process Development | Process Validation | R&D | Solid Dosage/Semi-solids | Toxicology | Validation
Keys to Successful Outsourcing
Teamwork and communication help break the development bottleneck.Harold Meckler, Ph.D and Kenton Shultis 08.22.05
-
APIs | Capsules | cGMP Manufacture | Chemistry | Clinical Trial Materials | Clinical Trials | Drug Delivery | Drug Development | Drug Discovery | Extractables and Leachables | Facilities | Fill/Finish | Formulation Development | GMPs/GCPs | Lyophilization | Microbiology | Preclinical Outsourcing | Process Development | Regulatory Affairs | Supply Chain | Validation
Top Contract Service and Outsourcing Companies
Editor Gil Roth profiles the top companies in the various pharma and biopharma outsourcing arenas, with analyst perspective from investment analyst Michael Martorelli.Gil Roth 08.22.05
